Integration of clinical and transcriptomics reveals programming of the lipid metabolism in gastric cancer

BMC Cancer

Table 1 Clinicopathological characteristics of gastric cancer patients grouped by lipid index

Characteristics	TC		TG		HDL		LDL
	< 5.1	≥5.1	< 1.7	≥1.7	≥1.42	< 1.42	< 3.1	≥3.1
Sex		0.159		< 0.001		0.003		0.003
Male	64	39	76	89	85	18	63	40
Female	272	83	266	27	240	115	269	86
T stage		0.001		0.004		< 0.001		0.001
T1	52	38	55	35	74	16	50	40
T2	47	19	50	16	53	13	49	17
T3	44	14	41	17	46	12	45	13
T4	193	51	196	48	152	92	188	56
N stage		0.016		0.001		0.463		0.013
N0	127	63	125	65	139	51	125	65
N1	55	20	63	12	55	20	54	21
N2	154	39	154	39	131	62	153	40
M stage		0.159		0.041		0.578		0.725
M0	306	116	310	112	298	124	305	117
M1	30	6	32	4	27	9	27	9
Stage		0.005		0.002		< 0.001		0.043
1	75	43	74	44	98	20	73	45
2	87	22	50	16	52	14	47	19
3	187	51	186	52	148	90	185	53
4	30	6	32	4	27	9	27	9
Chemotherapy		0.899		< 0.001		0.041		0.280
No	130	48	122	56	136	42	124	54
Yes	206	74	220	60	189	91	208	72
BMI		0.034		0.099		0.889		0.064
< 18.5	35	5	35	6	28	12	34	6
18.5–25	301	117	307	110	297	121	298	120

ISSN: 1471-2407